Reply to: Improving the Clinical Interpretability of Functional Drug Screens: A Suggestion for Standardized Clinical Decision Thresholds in Quadratic Phenotypic Optimization Platform
Authors:
- Wee Lee ChanWCWee Lee Chan
- Masturah Bte Mohd Abdul RashidMRMasturah Bte Mohd Abdul Rashid
- Rui Xue LeeRLRui Xue Lee
- Sanjay de MelSMSanjay de Mel
- Edward Kai-Hua ChowECEdward Kai-Hua Chow
- Anand D. JeyasekharanAJAnand D. Jeyasekharan
- 1 October 2025
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 9 (9) , e2500998
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- A Combinatorial Functional Precision Medicine Platform for Rapid Therapeutic Response Prediction in AMLCancer Medicine, 2024
- Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancersNature Medicine, 2024
- Functional Precision Medicine Vs Genomics Vs Clinical Experience: Feasibility Results from the Multicentric, Prospective, Randomized Controlled Exalt-2 TrialBlood, 2023
- Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trialsOncotarget, 2019
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989